| IBRANCE 100 mg film-coated tablets EU/1/16/1147/0012-013 |
Palbociclib |
Pfizer Europe MA EEIG |
— |
| IBRANCE 100 mg hard capsules EU/1/16/1147/003-004 |
Palbociclib |
Pfizer Europe MA EEIG |
— |
| IBRANCE 125 mg film-coated tablets EU/1/16/1147/014-015 |
Palbociclib |
Pfizer Europe MA EEIG |
— |
| IBRANCE 125 mg hard capsules EU/1/16/1147/005-006 |
Palbociclib |
Pfizer Europe MA EEIG |
— |
| IBRANCE 75 mg film-coated tablets EU/1/16/1147/010-011 |
Palbociclib |
Pfizer Europe MA EEIG |
— |
| IBRANCE 75 mg hard capsules EU/1/16/1147/001-002 |
Palbociclib |
Pfizer Europe MA EEIG |
— |
| Ibuprofen 200 mg soft capsules PA22749/022/004 |
Ibuprofen ph. eur. |
Brillpharma (Ireland) Limited |
Not marketed |
| Ibuprofen 200mg Film-coated tablets PA23341/002/001 |
Ibuprofen |
Hualan Pharmaceuticals Limited |
Not marketed |
| Ibuprofen 400mg Film-coated Tablets PA23341/002/002 |
Ibuprofen |
Hualan Pharmaceuticals Limited |
Not marketed |
| Ibuprofen 600mg Film-coated Tablets PA23341/002/003 |
Ibuprofen |
Hualan Pharmaceuticals Limited |
Not marketed |
| Ibuprofen Farmalider 200 mg film-coated tablets PA2090/002/001 |
Ibuprofen ph. eur. |
Farmalider S.A. |
Not marketed |
| Ibuprofen Gen.Orph 5 mg/mL solution for injection EU/1/23/1791/001 |
Ibuprofen |
Gen.Orph |
— |
| Icandra 50 mg/1000 mg film-coated tablets EU/1/08/484/007-012 |
|
Novartis Europharm Limited |
— |
| Icandra 50 mg/850 mg film-coated tablets EU/1/08/484/001-006 |
|
Novartis Europharm Limited |
— |
| Icatibant Accord 30 mg solution for injection in pre-filled syringe EU/1/21/1567/001-002 |
Icatibant |
Accord Healthcare S.L.U. |
— |
| Iclusig 15 mg film-coated tablets EU/1/13/839/001-002 |
Ponatinib hci |
Incyte Biosciences Distribution B.V. |
— |
| Iclusig 30 mg film-coated tablets EU/1/13/839/006 |
Ponatinib hci |
Incyte Biosciences Distribution B.V. |
— |
| Iclusig 45 mg film-coated tablets EU/1/13/839/003-004 |
Ponatinib hci |
Incyte Biosciences Distribution B.V. |
— |
| IDACIO 40 mg Solution for injection EU/1/19/1356/002 |
Adalimumab |
Fresenius Kabi Deutschland GmbH |
— |
| IDACIO 40 mg Solution for injection EU/1/19/1356/003 |
Adalimumab |
Fresenius Kabi Deutschland GmbH |
— |
| IDACIO 40 mg/0.8 ml Solution for injection EU/1/19/1356/001 |
Adalimumab |
Fresenius Kabi Deutschland GmbH |
— |
| Idefirix 11 mg powder for concentrate for solution for infusion EU/1/20/1471/001-002 |
Imlifidase |
Hansa Biopharma AB |
— |
| IDELVION 1000 IU powder and solvent for solution for injection EU/1/16/1095/003 |
Rix-fp |
CSL Behring GmbH |
— |
| IDELVION 2000 IU powder and solvent for solution for injection EU/1/16/1095/004 |
Rix-fp |
CSL Behring GmbH |
— |
| IDELVION 250 IU powder and solvent for solution for injection EU/1/16/1095/001 |
Rix-fp |
CSL Behring GmbH |
— |
| IDELVION 3500 IU powder and solvent for solution for injection EU/1/16/1095/009 |
Albutrepenonacog Alfa |
CSL Behring GmbH |
— |
| IDELVION 500 IU powder and solvent for solution for injection EU/1/16/1095/002 |
Rix-fp |
CSL Behring GmbH |
— |
| IELMAG3 0.2 mg kit for radiopharmaceutical preparation PA2226/001/001 |
Mertiatide |
ROTOP Pharmaka GmbH |
Marketed |
| Ifirmacombi 150 mg/12.5 mg film-coated tablets EU/1/11/673/001-008 |
Hydrochlorothiazide, Irbesartan |
KRKA, d.d., Novo mesto |
— |
| Ifirmacombi 300 mg/12.5 mg film-coated tablets EU/1/11/673/009-016 |
Hydrochlorothiazide, Irbesartan |
KRKA, d.d., Novo mesto |
— |
| Ifirmacombi 300 mg/25 mg film-coated tablets EU/1/11/673/017-024 |
Hydrochlorothiazide, Irbesartan |
KRKA, d.d., Novo mesto |
— |
| Ifirmasta 150 mg film-coated tablets EU/1/08/480/7-12 |
Irbesartan |
KRKA, d.d., Novo mesto |
— |
| Ifirmasta 300 mg film-coated tablets EU/1/08/480/13-18 |
Irbesartan |
KRKA, d.d., Novo mesto |
— |
| Ifirmasta 75 mg film-coated tablets EU/1/08/480/1-6 |
Irbesartan |
KRKA, d.d., Novo mesto |
— |
| IKERVIS 1 mg/mL eye drops, emulsion EU/1/15/990/001-002 |
Ciclosporin |
Santen OY |
— |
| Ilaris 150 mg powder for solution for injection EU/1/09/564/1-2 |
Canakinumab |
Novartis Europharm Limited |
— |
| Ilaris 150 mg/ml solution for injection EU/1/09/564/004 |
Canakinumab |
Novartis Europharm Limited |
— |
| Illuccix 25 micrograms kit for radiopharmaceutical preparation PA23504/001/001 |
Gozetotide |
Telix Innovations |
Not marketed |
| Ilumetri EU/1/18/1323/001 |
Tildrakizumab |
Almirall, S.A. |
— |
| Ilumetri 200 mg solution for injection in pre-filled syringe EU/1/18/1323/003 |
Tildrakizumab |
Almirall S.A. |
— |
| ILUVIEN 190 micrograms intravitreal implant in applicator PA22620/001/001 |
Fluocinolone acetonide |
Alimera Sciences Europe Limited, |
Marketed |
| Imatinib Accord 100 mg film-coated tablets EU/1/13/845/001-008 |
Imatinib mesilate |
Accord Healthcare S.L.U. |
— |
| Imatinib Accord 400 mg film-coated tablets EU/1/13/845/009-014 |
Imatinib mesilate |
Accord Healthcare S.L.U. |
— |
| Imatinib Teva 100 mg film-coated tablets EU/1/12/808/001-012 |
Imatinib mesilate |
Teva B.V. |
— |
| Imatinib Teva 100 mg hard capsules EU/1/12/808/021-032 |
Imatinib mesilate |
Teva Pharma B.V. |
— |
| Imatinib Teva 400 mg film-coated tablets EU/1/12/808/013-020 |
Imatinib mesilate |
Teva Pharma B.V. |
— |
| Imatinib Teva 400 mg hard capsules EU/1/12/808/033-040 |
Imatinib mesilate |
Teva Pharma B.V. |
— |
| IMBRUVICA 140 mg film-coated tablets EU/1/14/945/007-008 |
Ibrutinib |
Janssen-Cilag International NV |
— |
| IMBRUVICA 140 mg hard capsules EU/1/14/945/001-002 |
Ibrutinib |
Janssen-Cilag International NV |
— |
| IMBRUVICA 280 mg film-coated tablets EU/1/14/945/009-010 |
Ibrutinib |
Janssen-Cilag International NV |
— |